GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Pharmos Corporation (PARS) [hlAlert]

Pharmos Corporation (Pharmos) is a biopharmaceutical company that discovers and develops therapeutics to treat a range of diseases of the nervous system, including disorders of the brain-gut axis, with a focus on pain/inflammation, and autoimmune disorders. The Company?s product, dextofisopam, is developed for the treatment
of irritable bowel syndrome (IBS). On September 14, 2009, the Company announced the results of its Phase IIb Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome. Although the primary efficacy variable (% of weeks responding for adequate overall relief of IBS symptoms) did not reach statistical significance, the percentage responding for the Dextofisopam 200 milligram group was higher than that observed for the Phase IIa trial. However, the placebo response rate was also higher than expected compared to the Phase IIa placebo response.
.
( Total: 1 Current Stock Recommendations )
Pharmos Corporation   (1)
Hold 100%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  


* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy